Evidence map›Paper›PMID 27450937›Full record

ArticleUrology2016

An Approach Using PSA Levels of 1.5 ng/mL as the Cutoff for Prostate Cancer Screening in Primary Care.

E David Crawford, Matt T Rosenberg, Alan W Partin, Matthew R Cooperberg, Michael Maccini, Stacy Loeb, Curtis A Pettaway, Neal D Shore, Paul Arangua, John Hoenemeyer and 8 more

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Urology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Prostate cancer screening-when to start and how to screen?Translational andrology and urology · 2018
    Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 15 institutions in 3 countries.

E David CrawfordUniversity of Colorado Health Science Center, Aurora, CO. Electronic address: david.crawford@ucdenver.edu.
Matt T RosenbergMid-Michigan Health Centers, Jackson, MI.
Alan W PartinDepartment of Pathology, James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD.
Matthew R CooperbergDepartment of Urology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA.
Michael MacciniUniversity of Colorado Health Science Center, Aurora, CO.
Stacy LoebDepartment of Urology and Population Health, New York University, New York, NY.
Curtis A PettawayDepartment of Urology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX.
Neal D ShoreAtlantic Urology Clinics, Carolina Urologic Research Center, Myrtle Beach, SC.
Paul AranguaUniversity of Colorado Health Science Center, Aurora, CO.
John HoenemeyerUniversity of Colorado Health Science Center, Aurora, CO.
Mike LeveridgeDepartment of Urology, Department of Oncology, Kingston General Hospital, Queen's University, Kingston, ON.
Michael LeapmanDepartment of Urology, University of California, San Francisco, San Francisco, CA.
Peter PintoNational Cancer Institute, Center for Cancer Research, Bethesda, MD.
Ian M ThompsonDepartment of Urology, The University of Texas Health Science Center at San Antonio, San Antonio, TX.
Peter CarrollDepartment of Urology, University of California, San Francisco, San Francisco, CA.
James EasthamDepartment of Urology, Memorial Sloan Kettering Cancer Institute, New York, NY.
Leonard GomellaKimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA.
Eric A KleinCleveland Clinic, Glickman Urological & Kidney Institute, Cleveland, OH.
University of California, San Francisco · USUniversity of Colorado Health · USCarolina Urologic Research Center · USCenter for Cancer Research · USCleveland Clinic · USJohns Hopkins University · USMemorial Sloan Kettering Cancer Center · USMercy Health · USNew York University · USQueen's University · CASidney Kimmel Cancer Center · USThe University of Texas Health Science Center at San Antonio · USThe University of Texas MD Anderson Cancer Center · USUniversity of Colorado Denver · USUniversity of Colorado Hospital · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Elisa de Stanchina · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Early Detection of CancerHumansMalePractice Guidelines as TopicPrimary Health CareProstate-Specific AntigenProstatic NeoplasmsProstate-Specific Antigen

Identifiers

PMID27450937
PMCPMC5568096
OpenAlexW2486470779

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.